Genetic Technologies Limited (NASDAQ:GENE) is up by 28.38% this afternoon following its 2015 annual general meeting of shareholders where seven resolutions were passed. Some of the takeaways from the meeting include the re-election of Malcolm Brandon; the election of Eutillio Buccilli; and the ratification of a prior placement of shares to sophisticated investors. On November 23, Genetic Technologies Limited (NASDAQ:GENE) announced a publication that evaluated its BREVAGenplus® breast cancer risk assessment test, which also validated its applicability for use by African-American and Hispanic women. Two funds in our database held 3.50% of the company’s outstanding stock at the end of September.
Guess? Inc. (NYSE:GES) shares are up by 8.14% despite lower fiscal third-quarter 2015 results, including 7% lower retail revenue in the U.S, 15% lower revenue in Europe, and 17% lower revenue in Asia. Guess? Inc. (NYSE:GES) booked net earnings of $12.4 million, or $0.15 per share for the three months ended October 31, compared to $20.9 million, or $0.24 per share for the period ended November 1, 2014. Meanwhile, net revenue was reported at $520 million for the most recent quarter, compared to $589 million for the prior-year period.
Looking at Insider Monkey’s database, 15 funds held 8.40% of the company’s outstanding stock at the end of September. Gotham Asset Management, a hedge fund managed by Joel Greenblatt, holds 2.37 million shares of the company.